replication, as well as severe lung injury. Potential therapeutic approaches include (Figure 10):
FIGURE 10  Schematic representation of the potential therapeutic approaches to address ACE2 mediated infection. Exogenous administration of soluble recombinant human ACE 2 sequesters circulating viral particles, while specific ACE2 blockers bind the recepto